Policy experts say changes in expectations and funding key to genomic medicine's future

Feb 17, 2011

Unrealistic expectations about genomic medicine have created a "bubble" that needs deflating before it puts the field's long term benefits at risk, four policy experts write in the current issue of the journal Science.

Ten years after the deciphering of the was accompanied by over-hyped promises of medical breakthroughs, it may be time to reevaluate funding priorities to better understand how to change behaviors and reap the health benefits that would result.

In addition, the authors say, scientists need to foster more realistic understanding about how scientific research works "by making responsible claims and by advocating that reporters and editors do the same."

"Our fear is that if we are uncritical and naïve in our enthusiasm for these exciting technologies we risk both diversion of precious resources and premature implementation, which could hurt patients, as well as produce a backlash, which will hurt our field," said lead author medical geneticist James P. Evans, M.D., Ph.D., Bryson Distinguished Professor of Genetics and Medicine at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center.

"We feel it's time to assess the progress made towards achieving the hoped-for benefits from genomic science," said Eric M. Meslin, Ph.D., director of the Indiana University Center for Bioethics and one of the commentary's co-authors. "While we remain excited about the science, we also think the time has come to ask why the pace of progress has been slower than expected and what science and society might do about it."

The commentary appears in the Feb. 18, 2011, issue of the journal Science. Co-authors with Evans and Meslin are Theresa M. Marteau, Ph.D., F.Med.Sci., professor of health psychology, Kings College, London, UK; and Timothy Caulfield, LL.M., F.R.S.C., Canada Research Chair in Health Law & Policy, at the University of Alberta.

The authors agree that progress in genomic research has been "breathtaking," noting, as an example, that routine whole-genome sequencing may soon be a reality. But, they caution, the considerable promise of genomics must be evaluated through a realistic lens. After all, while advances are being made in personalized medicine through the tools of pharmacogenetics, "the most powerful predictor of drug efficacy is whether a patient takes the drug."

• In many diseases a large number of genes play a role, making meaningful predictions difficult both for individuals and in public health.

• There's little evidence that advising people they are at genetically increased risk for disease has significant impact on their behavior, while telling others they are at less risk can promote bad behaviors.

• Translating scientific findings into patient care is an "inherently messy" process, as demonstrated by hormone replacement therapy and other "ideas that didn't pan out when scrutinized through the lens of evidence-based medicine."

Even so, the authors write, the benefits of genomic research will come, resulting in understanding the mechanisms of disease, improved diagnostics and better therapies – but those benefits will be decades in the making.

The authors offer their short list of recommendations, including "a reappraisal of the apportioning of research funds" and efforts to help more people understand that progress in science is incremental.

In addition, they recommend maintaining focus on developing high quality evidence before moving new ideas into patient care, while also developing new ways to assess clinical evidence so promising new treatments are not delayed.

"We believe that the current age of genomics will provide great benefits to human health … Ours is not a call to gut existing research or too-rigidly tie funding to degree of disease burden," the authors assert.

"The pursuit of our common goal – improved human health – demands that we take a hard look at disease causation and order our priorities accordingly."

Explore further: Study identifies genetic change in autism-related gene

Provided by Indiana University School of Medicine

not rated yet

Related Stories

Public health in the genomic era: A global issue

Nov 30, 2010

The major challenge for public health in the era of genomics is to generate the base of evidence necessary to demonstrate when use of genomic information in public health can improve health outcomes in a safe, effective and ...

Perspective: Policies must keep pace with genetic progress

Jun 19, 2008

Enactment of the Genetic Information Nondiscrimination Act (GINA) of 2008 is a boon to individual patients and for genetic research, write Kathy Hudson, M.K. Holohan, and Francis Collins in the June 19 issue of the New En ...

NHGRI charts course for the next phase of genomics research

Feb 09, 2011

A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next ...

Recommended for you

Study identifies genetic change in autism-related gene

17 hours ago

A new study from Bradley Hospital has identified a genetic change in a recently identified autism-associated gene, which may provide further insight into the causes of autism. The study, now published online in the Journal of ...

NIH issues finalized policy on genomic data sharing

Aug 27, 2014

The National Institutes of Health has issued a final NIH Genomic Data Sharing (GDS) policy to promote data sharing as a way to speed the translation of data into knowledge, products and procedures that improve health while ...

The genes behind the guardians of the airways

Aug 27, 2014

Dysfunctions in cilia, tiny hair-like structures that protrude from the surface of cells, are responsible for a number of human diseases. However the genes involved in making cilia have remained largely elusive. ...

Cancer leaves a common fingerprint on DNA

Aug 25, 2014

Regardless of their stage or type, cancers appear to share a telltale signature of widespread changes to the so-called epigenome, according to a team of researchers. In a study published online in Genome Me ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

ArtflDgr
not rated yet Mar 04, 2011
When do policy experts say anything ELSE but we need more money

How hard is it to be a policy expert if all you have to do is make up crap to justify the same message all the time?

You know, if we fire all the policy experts we would have their salaries to dole out
I mean, they never say anything else as the point, so why pay for them to gild that lilly in variations on a theme?

Just take their salaries and spread it out to people knowing that if you paid them.
they would say more money is needed anyway.